Entity Details

Primary name MAF
Entity type gene
Source Source Link

Details

PrimaryID4094
RefseqGeneNG_016440
SymbolMAF
NameMAF bZIP transcription factor
Chromosome16
Location16q23.2
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1995-03-30
ModificationDate2021-06-12

Ontological Relatives

UniProt IDsMAF_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000122 negative regulation of transcription by RNA polymerase II
GO:0000785 chromatin
GO:0000978 RNA polymerase II cis-regulatory region sequence-specific DNA binding
GO:0000981 DNA-binding transcription factor activity, RNA polymerase II-specific
GO:0001228 DNA-binding transcription activator activity, RNA polymerase II-specific
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0006357 regulation of transcription by RNA polymerase II
GO:0006366 transcription by RNA polymerase II
GO:0010628 positive regulation of gene expression
GO:0032330 regulation of chondrocyte differentiation
GO:0048468 cell development
GO:0048839 inner ear development
GO:0070306 lens fiber cell differentiation
GO:1990837 sequence-specific double-stranded DNA binding

Diseases

Show/Hide Table
Disease IDSourceNameDescription
601088 OMIMAyme-Gripp syndrome (AYGRP)A multisystem disorder characterized by congenital cataracts, sensorineural deafness, intellectual disability, seizures, brachycephaly, distinctive flat facial appearance, skeletal anomalies, mammary gland hypoplasia, and reduced growth. The disease is caused by variants affecting the gene represented in this entry.
610202 OMIMCataract 21, multiple types (CTRCT21)An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT21 includes cerulean and pulverulent cataracts. Cerulean cataracts are characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract. Pulverulent cataracts are characterized by a dust-like, 'pulverised' appearance of the opacities which can be found in any part of the lens. In some cases cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. The disease is caused by variants affecting the gene represented in this entry.

Interactions

63 interactions

InteractorPartnerSourcesPublicationsLink
MAFBACH1HPIDb20102225 details
MAFMAFBBioGRID, HPIDb, UniProt20102225 23661758 details
MAFATF4BioGRID, HPIDb, UniProt20102225 23661758 details
MAFMAFBioGRID, HPIDb, HPRD, UniProt12011435 12149651 20102225 23661758 details
MAFJUNBUniProt23661758 details
MAFFOSL1BioGRID, UniProt23661758 details
MAFEP300BioGRID, HPRD11943779 details
MAFUSF2BioGRID, HPRD9070273 details
MAFSOX9BioGRID, HPRD12381733 details
MAFMYBBioGRID, HPRD9566892 details
MAFETS1BioGRID, HPRD9566892 details
MAFMAFGBioGRID, HPRD12149651 details
MAFHOXD12BioGRID11036080 details
MAFFOSBioGRID, HPRD21163924 23661758 8108109 details
MAFUBE2OBioGRID28673317 32842143 details
MAFAHRBioGRID, InnateDB20676092 20676095 details
MAFCREBBPBioGRID, HPRD11943779 details
MAFKDM5BBioGRID19336002 details
MAFCEBPABioGRID17082780 details
MAFSMARCA5BioGRID, HPRD16675956 details
MAFHDAC2BioGRID17287852 details
MAFSIN3ABioGRID17287852 details
MAFUBE2IBioGRID19553542 details
MAFPMLBioGRID19553542 details
MAFNFE2L2BioGRID26078718 details
MAFUSP5BioGRID28933784 31197245 32842143 details
MAFUSP7BioGRID31822558 details
MAFOTUB1BioGRID32842143 details
MAFJUNHPRD8108109 details
MAFMAFAHPRD12011435 details
MAFRNF4BioGRID29180619 details
MAFPSMA1BioGRID32842143 details
MAFPSMA3BioGRID32842143 details
MAFPSMA4BioGRID32842143 details
MAFPSMA5BioGRID32842143 details
MAFPSMA6BioGRID32842143 details
MAFPSMA7BioGRID32842143 details
MAFPSMB7BioGRID32842143 details
MAFPSMC1BioGRID32842143 details
MAFPSMC2BioGRID32842143 details
MAFPSMC3BioGRID32842143 details
MAFPSMC4BioGRID32842143 details
MAFPSMC5BioGRID32842143 details
MAFPSMC6BioGRID32842143 details
MAFPSMD1BioGRID32842143 details
MAFPSMD11BioGRID32842143 details
MAFPSMD12BioGRID32842143 details
MAFPSMD13BioGRID32842143 details
MAFPSMD14BioGRID32842143 details
MAFPSMD3BioGRID32842143 details
MAFPSMD4BioGRID32842143 details
MAFPSMD6BioGRID32842143 details
MAFPSMD7BioGRID32842143 details
MAFPSMD8BioGRID32842143 details
MAFPSME3BioGRID32842143 details
MAFHUWE1BioGRID32842143 details
MAFUBR5BioGRID32842143 details
MAFRNF114BioGRID32842143 details
MAFHERC4BioGRID32842143 details
MAFUBA1BioGRID32842143 details
MAFSTAT3IntAct30413785 details
MAFROCK2IntAct30413785 details
MAFHNRNPLBioGRID28611215 details